Georg Schett

机构：Karolinska University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Agostino Gemelli University Polyclinic, Universitätsklinikum Erlangen · ORCID：0000-0001-8740-9615

发表论文 1702 篇 · 总被引 101924 次 · h-index 156

代表论文

• CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial (2026 · Nature Medicine · 被引 56)
• BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease (2025 · New England Journal of Medicine · 被引 28)
• Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial (2025 · Nature Medicine · 被引 17)
• Mucosal innate immune activation as the trigger to Prevotella species-induced arthritis in genetically resistant mice (2026 · Cell Reports · 被引 12)
• Key considerations for advancing chimeric antigen receptor (CAR) T-cell therapy for systemic lupus erythematosus (SLE): a multi-partner/disciplinary working group perspective (2025 · RMD Open · 被引 5)
• Tiny warriors, big impact: targeted immunotherapy in kidney diseases (2026 · Kidney International · 被引 3)